●Interviews and Reports at the World Medical Association's General Assembly at Helsinki (forthcoming) |
||||||
●For the 2024 revision of the Declaration of Helsinki (Part 2): Webinar proceedings and statements from external stakeholders |
||||||
・Proceedings 〔Webinar information (video, slides, etc.)〕 | ||||||
The 2024 Declaration of Helsinki: Taking Forward Bioethics and Human Rights Co-organized by The Brazilian Society of Bioethics (SBB); International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP); Clinical Evaluation Inc.; The 129th Pharmaceutical Study Group Supported by The Japan Association for Bioethics (JAB) Cooperation: Japanese Association of Pharmaceutical Medicine (JAPhMed); Japanese Institute for Public Engagement (Ji4pe); Clinical Research Risk Management Study Group | Elda Coelho de Azevedo Bussinguer, Dirceu Greco, Varvara Baroutsou,et al. | |||||
・Interview | ||||||
Interview with Dr. Peter Lurie on the ethical controversies of placebo-controlled trials -As a part of the program of webinar on the 2024 Declaration of Helsinki: Taking forward Bioethics and Human Rights- |
Peter Lurie (Interviewed by Chieko Kurihara) | |||||
・Articles | ||||||
Patient Public Declaration of Research Ethics (1st edition): Research ethics of the people, by the people, for the people -Expanding the impact of 2024 revision of the Declaration of Helsinki | Chieko Kurihara, Yoshiko Saito, Hiroto Kai,et al. |
|||||
Opinion: Noblesse oblige of the WMA in peril: Saving its honor at the Diamond Anniversary | Takeo Saio | |||||
Helsinki Statement from an Independent Stakeholders’ Group to Expand the Impact of the 2024 Revision of the WMA Declaration of Helsinki ・Japanese ・Arabic |
Helsinki Statement an ad hoc group of stakeholders |
|||||
・Translations | ||||||
Declaration of Helsinki: Ethical norm in pursuit of common global goals (Japanese translation) ・Original publication in English |
Chieko Kurihara, Sandor Kerpel-Fronius, Sander Becker, Anthony Chan,et al. |
|||||
Vulnerability, social value and the equitable sharing of benefits from research: Beyond the placebo and access debates (Japanese translation) ・Original publication in English |
Chieko Kurihara, Dirceu Greco, Ames Dhai,et al. |
|||||